VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $269,000 | -37.0% | 1,209 | -43.7% | 0.01% | -42.1% |
| Q1 2015 | $427,000 | +36.4% | 2,148 | -1.7% | 0.02% | +26.7% |
| Q4 2014 | $313,000 | +22.7% | 2,185 | +12.2% | 0.02% | +15.4% |
| Q3 2014 | $255,000 | -8.9% | 1,947 | -12.2% | 0.01% | -18.8% |
| Q2 2014 | $280,000 | -4.1% | 2,218 | 0.0% | 0.02% | -20.0% |
| Q1 2014 | $292,000 | -55.6% | 2,218 | -60.4% | 0.02% | -60.0% |
| Q4 2013 | $658,000 | +7.5% | 5,604 | +0.6% | 0.05% | -5.7% |
| Q3 2013 | $612,000 | +200.0% | 5,571 | +135.2% | 0.05% | +152.4% |
| Q2 2013 | $204,000 | – | 2,369 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |